Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
生物标志物在肿瘤学中的应用能否降低临床试验失败的风险?一项大规模分析
期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.3732
Parker, Jayson L; Kuzulugil, Sebnem S; Pereverzev, Kirill; Mac, Stephen; Lopes, Gilberto; Shah, Zain; Weerasinghe, Ashini; Rubinger, Daniel; Falconi, Adam; Bener, Ayse; Caglayan, Bora; Tangri, Rohan; Mitsakakis, Nicholas